Because Th2 differentiation is dependent on IL-4 or IL-13 signaling, Avraham et al. utilized monoclonal IL-4 and IL-13 antibodies in the mouse tail surgery model and found that blockade of these cytokines prevented development of lymphedema after tail injury and resulted in significant improvement in animals with established disease [41]. The gene discussed is IL13; the disease is lymphedema.